ArticleBreast cancer (Tokyo, Japan)2026

The value of LAR in predicting neoadjuvant therapy response and prognosis in HER2-positive breast cancer.

Xiaojing Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.